日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Combinatorial screen of targeted agents with the PI3K inhibitors inavolisib, alpelisib, duvelisib, and copanlisib in multi-cell type tumor spheroids.

在多细胞类型肿瘤球体中,对靶向药物与 PI3K 抑制剂 inavolisib、alpelisib、duvelisib 和 copanlisib 进行组合筛选

Dexheimer Thomas S, Davoudi Zahra, Coussens Nathan P, Silvers Thomas, Morris Joel, Takebe Naoko, Said Rabih, Moscow Jeffrey A, Doroshow James H, Teicher Beverly A

Aplastic anemia secondary to dual cancer immunotherapies a physician nightmare: case report and literature review

双重癌症免疫疗法继发的再生障碍性贫血:医生的噩梦——病例报告及文献综述

Younan, Romy G; Raad, Roy A; Sawan, Bassem Y; Said, Rabih

Primary Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: The MD Anderson Cancer Center Experience

原发性肾脏尤文氏肉瘤/原始神经外胚层肿瘤:MD安德森癌症中心的经验

Tarek, Nidale; Said, Rabih; Andersen, Clark R; Suki, Tina S; Foglesong, Jessica; Herzog, Cynthia E; Tannir, Nizar M; Patel, Shreyaskumar; Ratan, Ravin; Ludwig, Joseph A; Daw, Najat C

Management of patients with high-risk and advanced prostate cancer in the Middle East: resource-stratified consensus recommendations

中东地区高危和晚期前列腺癌患者的管理:基于资源分层的共识建议

Mukherji, Deborah; Youssef, Bassem; Dagher, Christelle; El-Hajj, Albert; Nasr, Rami; Geara, Fadi; Rabah, Danny; Al Dousari, Saad; Said, Rabih; Ashou, Raja; Wazzan, Wassim; Jabbour, Michel; Farha, George; Al Hamdani, Nibras; Al Hallaq, Yousuf; Ghazal, Hassan; Dbouk, Haifa; Bachir, Bassel; El Khoury, Clement; Sakr, Ghazi; Hussain, Hero K; Sayyid, Khaled; Ibrahim, Khaled; Haidar, Mohammad; Zouain, Nicolas; Bitar, Nizar; Alameh, Walid; Abbas, Fadi; Faddoul, Sami; Nemer, Elie; Assaf, Georges; Farhat, Fadi; Bulbul, Muhammad; Temraz, Sally; Shamseddine, Ali; Gillessen, Silke; Omlin, Aurelius; Khauli, Raja

Circulating tumor DNA analysis in the era of precision oncology

精准肿瘤学时代的循环肿瘤DNA分析

Said, Rabih; Guibert, Nicolas; Oxnard, Geoffrey R; Tsimberidou, Apostolia M

Basket Trials and the MD Anderson Precision Medicine Clinical Trials Platform

篮子试验和MD安德森精准医学临床试验平台

Said, Rabih; Tsimberidou, Apostolia-Maria

Expanded access to investigational drugs: balancing patient safety with potential therapeutic benefits

扩大试验性药物的使用范围:平衡患者安全与潜在治疗获益

Fountzilas, Elena; Said, Rabih; Tsimberidou, Apostolia M

Phase I study of azacitidine and oxaliplatin in patients with advanced cancers that have relapsed or are refractory to any platinum therapy

一项针对复发或对任何铂类药物均耐药的晚期癌症患者的阿扎胞苷和奥沙利铂的I期研究

Tsimberidou, Apostolia M; Said, Rabih; Culotta, Kirk; Wistuba, Ignacio; Jelinek, Jaroslav; Fu, Siqing; Falchook, Gerald; Naing, Aung; Piha-Paul, Sarina; Zinner, Ralph; Siddik, Zahid H; He, Guangan; Hess, Kenneth; Stewart, David J; Kurzrock, Razelle; Issa, Jean-Pierre J

Dose-finding study of hepatic arterial infusion of irinotecan-based treatment in patients with advanced cancers metastatic to the liver

伊立替康肝动脉灌注治疗晚期肝转移癌患者的剂量探索研究

Said, Rabih; Kurzrock, Razelle; Naing, Aung; Hong, David S; Fu, Siqing; Piha-Paul, Sarina A; Wheler, Jennifer J; Janku, Filip; Kee, Bryan K; Bidyasar, Savita; Lim, Joann; Wallace, Michael; Tsimberidou, Apostolia M

Phase I study of BIIB028, a selective heat shock protein 90 inhibitor, in patients with refractory metastatic or locally advanced solid tumors

BIIB028(一种选择性热休克蛋白90抑制剂)治疗难治性转移性或局部晚期实体瘤患者的I期研究

Hong, David; Said, Rabih; Falchook, Gerald; Naing, Aung; Moulder, Stacy; Tsimberidou, Apostolia-Maria; Galluppi, Gerald; Dakappagari, Naveen; Storgard, Chris; Kurzrock, Razelle; Rosen, Lee S